Internal Medicine, Gastroenterology · Las Vegas, NV
NPI
1376644344
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2701 N Tenaya Way Ste 100
Las Vegas, NV, 89128
Phone (702) 483-5515
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
708 services
Medicare patients, 2024
342
Average age 73
Drug cost, 2024
$2.3M
4,130 prescriptions
Company payments, 2025
$2,795
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frank Faris was code 99213 (office e&m - established), 297 times for 216 patients. In total Frank Faris billed 708 services in 24 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 297 | 216 | $55.76 | $17K |
| 99203 Office E&M - New | Office | 171 | 171 | $61.92 | $11K |
| 45385 Colonoscopy - Lesion Removal | Facility | 69 | 69 | $166.94 | $12K |
| 43239 Upper GI Endoscopy | Facility | 66 | 66 | $59.02 | $3,895 |
| 45378 Lower GI Endoscopy - Other | Facility | 28 | 27 | $111.56 | $3,124 |
| 99202 Office E&M - New | Office | 14 | 14 | $32.88 | $460 |
| 45380 Lower GI Endoscopy - Other | Facility | 14 | 14 | $77.34 | $1,083 |
By year: 2022 $100K for 1,127 services; 2023 $75K for 878 services; 2024 $53K for 708 services.
Medicare prescription drug claims, 2024
In 2024, the drug Frank Faris prescribed most often to Medicare patients was Pantoprazole Sodium, with 867 prescriptions and refills. In total Frank Faris wrote 4,130 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 867 | 1,719 | 266 | $6,589 |
| Famotidine Generic | 581 | 1,177 | 193 | $7,577 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 226 | 226 | 222 | $39K |
| Ondansetron Odt Ondansetron | 224 | 225 | 175 | $1,029 |
| Omeprazole Generic | 220 | 439 | 57 | $2,529 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 131 | 131 | 121 | $1,831 |
| Sucralfate Generic | 114 | 201 | 43 | $1,123 |
| Glycopyrrolate Generic | 110 | 116 | 25 | $317K |
| Dicyclomine Hcl Generic | 109 | 211 | 38 | $1,772 |
| Linzess Linaclotide | 82 | 134 | 28 | $70K |
| Hydrocortisone Generic | 72 | 76 | 47 | $709 |
| Cholestyramine Light Cholestyramine | 65 | 109 | 32 | $4,734 |
| Azathioprine Generic | 50 | 110 | 14 | $1,820 |
| Ursodiol Generic | 49 | 81 | Under 11 | $4,926 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 45 | 45 | 15 | $1,590 |
Brand drugs: - claims; generic drugs: 3,455 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frank Faris $2,795 ($2,795 in general payments such as food, travel and fees) from 14 companies. The largest payer was Intra-Sana Laboratories with $735.
| Company | Payments | Amount |
|---|---|---|
| Intra-Sana Laboratories | 46 | $735 |
| Abbvie Inc. ABBV | 26 | $675 |
| Janssen Biotech, Inc. JNJ | 22 | $643 |
| Genzyme Corporation SNY | 11 | $182 |
| Gilead Sciences, Inc. GILD | 2 | $140 |
| Pfizer Inc. PFE | 6 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $84.9 |
| Lilly USA, LLC LLY | 2 | $42.42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $39.83 |
| Aimmune Therapeutics, Inc. | 2 | $35.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.